
### [MONDO:0018841](http://purl.obolibrary.org/obo/MONDO_0018841)
**Label:** congenital bile acid synthesis defect

**Subclasses:** [MONDO:0008967](http://purl.obolibrary.org/obo/MONDO_0008967) (congenital bile acid synthesis defect 4), 

**Corr. equiv. classes:** [Orphanet:79095](http://www.orpha.net/ORDO/Orphanet_79095), [OMIM:214950](http://purl.obolibrary.org/obo/OMIM_214950), [OMIM:614307](http://purl.obolibrary.org/obo/OMIM_614307), 

**Class expressions from DL-Learner:**

- [HP:0025155](http://purl.obolibrary.org/obo/HP_0025155) (Abnormality of hepatobiliary system physiology) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 66.67%
- [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 66.67%
- [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 66.67%
- [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 66.67%
- [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 66.67%
- [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 66.67%
- [HP:0006579](http://purl.obolibrary.org/obo/HP_0006579) (Prolonged neonatal jaundice) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 66.67%
- [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 66.67%
- [HP:0003623](http://purl.obolibrary.org/obo/HP_0003623) (Neonatal onset) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 66.67%
- [HP:0003271](http://purl.obolibrary.org/obo/HP_0003271) (Visceromegaly) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 66.67%
- [HP:0003256](http://purl.obolibrary.org/obo/HP_0003256) (Abnormality of the coagulation cascade) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 66.67%
- [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 66.67%
- [HP:0002244](http://purl.obolibrary.org/obo/HP_0002244) (Abnormality of the small intestine) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 66.67%
- [HP:0002242](http://purl.obolibrary.org/obo/HP_0002242) (Abnormality of the intestine) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 66.67%
- [HP:0002240](http://purl.obolibrary.org/obo/HP_0002240) (Hepatomegaly) and [HP:0200084](http://purl.obolibrary.org/obo/HP_0200084) (Giant cell hepatitis) 66.67%


